TrialCancer biology & therapy2012

A pilot study of paclitaxel combined with gemcitabine followed by interleukin-2 and granulocyte macrophage colony-stimulating factor for patients with metastatic melanoma.

Rui-Qing Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.